296 related articles for article (PubMed ID: 33390447)
1. [Ocular Drug Delivery System-based on Solid Nanoparticles].
Nagai N
Yakugaku Zasshi; 2021; 141(1):47-53. PubMed ID: 33390447
[TBL] [Abstract][Full Text] [Related]
2. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability.
Nagai N; Ito Y; Okamoto N; Shimomura Y
Toxicology; 2014 May; 319():53-62. PubMed ID: 24598350
[TBL] [Abstract][Full Text] [Related]
3. Energy-dependent endocytosis is responsible for drug transcorneal penetration following the instillation of ophthalmic formulations containing indomethacin nanoparticles.
Nagai N; Ogata F; Otake H; Nakazawa Y; Kawasaki N
Int J Nanomedicine; 2019; 14():1213-1227. PubMed ID: 30863055
[TBL] [Abstract][Full Text] [Related]
4. Combination with l-Menthol Enhances Transdermal Penetration of Indomethacin Solid Nanoparticles.
Nagai N; Ogata F; Yamaguchi M; Fukuoka Y; Otake H; Nakazawa Y; Kawasaki N
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31349657
[TBL] [Abstract][Full Text] [Related]
5. Fixed-Combination Eye Drops Based on Fluorometholone Nanoparticles and Bromfenac/Levofloxacin Solution Improve Drug Corneal Penetration.
Otake H; Goto R; Ogata F; Isaka T; Kawasaki N; Kobayakawa S; Matsunaga T; Nagai N
Int J Nanomedicine; 2021; 16():5343-5356. PubMed ID: 34413642
[TBL] [Abstract][Full Text] [Related]
6. Effect of solid nanoparticle of indomethacin on therapy for rheumatoid arthritis in adjuvant-induced arthritis rat.
Nagai N; Ito Y
Biol Pharm Bull; 2014; 37(7):1109-18. PubMed ID: 24989003
[TBL] [Abstract][Full Text] [Related]
7. [Design of Novel Ophthalmic Formulation Containing Drug Nanoparticles and Its Usefulness as Anti-glaucoma Drugs].
Nagai N
Yakugaku Zasshi; 2016; 136(10):1385-1390. PubMed ID: 27725388
[TBL] [Abstract][Full Text] [Related]
8. Topical therapies for rheumatoid arthritis by gel ointments containing indomethacin nanoparticles in adjuvant-induced arthritis rat.
Nagai N; Yoshioka C; Ito Y
J Oleo Sci; 2015; 64(3):337-46. PubMed ID: 25757439
[TBL] [Abstract][Full Text] [Related]
9. Improved corneal toxicity and permeability of tranilast by the preparation of ophthalmic formulations containing its nanoparticles.
Nagai N; Ono H; Hashino M; Ito Y; Okamoto N; Shimomura Y
J Oleo Sci; 2014; 63(2):177-86. PubMed ID: 24420060
[TBL] [Abstract][Full Text] [Related]
10. Optimization of the Interaction between Diclofenac and Ibuprofen with Benzalkonium Chloride to Prepare Ocular Nanosuspension.
Tak D; Rimpy ; Kumar T; Ahuja M
Recent Pat Drug Deliv Formul; 2019; 13(4):301-309. PubMed ID: 31849291
[TBL] [Abstract][Full Text] [Related]
11. Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study.
Bertoni S; Albertini B; Ferraro L; Beggiato S; Dalpiaz A; Passerini N
Eur J Pharm Biopharm; 2019 Jun; 139():132-141. PubMed ID: 30910731
[TBL] [Abstract][Full Text] [Related]
12. Improved ocular bioavailability of indomethacin by novel ocular drug carriers.
Calvo P; Alonso MJ; Vila-Jato JL; Robinson JR
J Pharm Pharmacol; 1996 Nov; 48(11):1147-52. PubMed ID: 8961163
[TBL] [Abstract][Full Text] [Related]
13. Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use.
Asasutjarit R; Theerachayanan T; Kewsuwan P; Veeranodha S; Fuongfuchat A; Ritthidej GC
AAPS PharmSciTech; 2015 Oct; 16(5):1013-24. PubMed ID: 25609376
[TBL] [Abstract][Full Text] [Related]
14. A Nanoparticle-Based Ophthalmic Formulation of Dexamethasone Enhances Corneal Permeability of the Drug and Prolongs Its Corneal Residence Time.
Nagai N; Nakazawa Y; Ito Y; Kanai K; Okamoto N; Shimomura Y
Biol Pharm Bull; 2017; 40(7):1055-1062. PubMed ID: 28674248
[TBL] [Abstract][Full Text] [Related]
15. Energy-Dependent Endocytosis Is Responsible for Skin Penetration of Formulations Based on a Combination of Indomethacin Nanoparticles and l-Menthol in Rat and Göttingen Minipig.
Otake H; Yamaguchi M; Ogata F; Deguchi S; Yamamoto N; Sasaki H; Kawasaki N; Nagai N
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066280
[TBL] [Abstract][Full Text] [Related]
16. The Toxicity of Nonsteroidal Anti-inflammatory Eye Drops against Human Corneal Epithelial Cells in Vitro.
Lee JS; Kim YH; Park YM
J Korean Med Sci; 2015 Dec; 30(12):1856-64. PubMed ID: 26713063
[TBL] [Abstract][Full Text] [Related]
17. Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration.
Abrego G; Alvarado H; Souto EB; Guevara B; Bellowa LH; Parra A; Calpena A; Garcia ML
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):261-70. PubMed ID: 25681744
[TBL] [Abstract][Full Text] [Related]
18. In Situ Gelling Systems Using Pluronic F127 Enhance Corneal Permeability of Indomethacin Nanocrystals.
Nagai N; Isaka T; Deguchi S; Minami M; Yamaguchi M; Otake H; Okamoto N; Nakazawa Y
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992931
[TBL] [Abstract][Full Text] [Related]
19. [Improvement of Dissolution Rate and Stability in a Pirenoxine Ophthalmic Suspension by the Bead Mill Methods].
Ueno A; Yamaoka S; Ito Y; Kotake T; Nakazawa Y; Nagai N
Yakugaku Zasshi; 2017; 137(5):635-641. PubMed ID: 28458295
[TBL] [Abstract][Full Text] [Related]
20. A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure.
Nagai N; Yoshioka C; Mano Y; Tnabe W; Ito Y; Okamoto N; Shimomura Y
Exp Eye Res; 2015 Mar; 132():115-23. PubMed ID: 25633346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
